PATENT CLAIM ANALYSIS

Application Number: 16070220
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-08
Patent Classification: ["424", "184100"]

Abstract:
The present invention relates to an immunomodulator for the prevention or treatment of an allergic disease caused by house dust mite-derived allergens. Particularly, the present invention provides an immunomodulatory pharmaceutical composition comprising as an effective ingredient a bacteria extracellular vesicle containing an allergens derived from North American house dust mite or European house dust mite, and a preparation method therefor.

Claim (Index 19):
The method of  claim 12 , wherein the composition is administered to the subject multiple times.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 1.3617
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13499653', '09513645', '13314024', '12934418', '12572599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7096962289954485
- 35 USC 102 Novelty (BERT): 0.5282126284082362
- Combined Prediction Score: 0.6915478689367274
- Mean Citation Score: 285.39262800000006
- Max Citation Score: 297.10016
- Similarity Product: 138.82917540056226

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test